GSK delivers Q1 sales of £7.2 billion, -2% AER, +4% CER
Read more - GSK delivers Q1 sales of £7.2 billion, -2% AER, +4% CER Read more
Press releases
These press releases are intended for business journalists and analysts/investors
Discontinuation of Typherix adult vaccine
Read more - Discontinuation of Typherix adult vaccine Read more
GSK launches Discovery Fast Track: Australian Challenge in search of early drug discovery partnerships with local researchers
New report aims to broaden understanding of how new medicines are funded in Australia
GSK and ViiV Healthcare aim to ‘pull back the curtain’ on the PBS with a video and report that explain how the Government assesses new medicines and vaccines.
Australians embrace digital health but privacy remains top concern
Results of a new study commissioned by GlaxoSmithKline Australia (GSK) reveal that Australians are in a bind when it comes to healthcare digitisation.
Read more - Australians embrace digital health but privacy remains top concern Read more
GSK response to ACCC Voltaren comparison investigation
Read more - GSK response to ACCC Voltaren comparison investigation Read more
Update on GSK hepatitis vaccine availability
Read more - Update on GSK hepatitis vaccine availability Read more
Anne Belcher, Head of GSK Australia Pharmaceuticals, appointed to Medicines Australia Board
Leukaemia pioneer “customising” cancer treatment receives major research award
Prof. Timothy Hughes wins GSK Award for Research Excellence 2017
Clinical trials vital to making new discoveries, says winner
Read more - Leukaemia pioneer “customising” cancer treatment receives major research award Read more
TGA approves MENVEO® vaccine to help protect babies from two months old from meningococcal disease
First ACWY combination vaccine available for use in infants under 12 months old, most at risk from meningococcal disease